Advertisement

Advertisement

Most Viewed Videos
Robert A. Figlin, MD, on RCC: Results From the ADAPT Trial
Sagar Lonial, MD, on Multiple Myeloma: Sequencing Therapies
Amy J. Davidoff, PhD, on Racial Disparities in Time to Cancer Treatment: The Effect of Medicaid Expansion
Sara A. Hurvitz, MD, on HR+/HER2− Advanced Breast Cancer: MONALEESA-7 Trial on Endocrine Therapy With or Without Ribociclib
Eva M. Ciruelos, MD, PhD, on HER2-Positive Breast Cancer: Results From the PATRICIA Trial
Jonathan W. Friedberg, MD, on Follicular Lymphoma: Novel Combination Therapies
Xavier Pivot, MD, PhD, on Early Breast Cancer: Results From the PHARE Trial
Julie M. Vose, MD, MBA, on Lymphoma: Novel Pathways for Targeted Agents
Kamal Chamoun, MD, on Multiple Myeloma: Insurance Status and Survival
Alok A. Khorana, MD, and Hedy L. Kindler, MD, on Metastatic Pancreatic Cancer: POLO Trial on Olaparib as Maintenance Therapy
Richard L. Schilsky, MD, and R. Donald Harvey, PharmD, BCOP, on Advanced Non–Small Cell Lung Cancer: Expanding the Criteria for Clinical Trial Eligibility
Ian D. Davis, MBBS, PhD, and Christopher Sweeney, MBBS, on Prostate Cancer: ENZAMET Trial on Enzalutamide for Metastatic Hormone-Sensitive Disease
Brian I. Rini, MD, on Renal Cell Carcinoma: Results From the TIVO-3 Trial on Tivozanib vs Sorafenib
John G. Gribben, MD, DSc, on The Tumor Microenvironment, Prognosis, and Outcome
Chrysalyne Schmults, MD, on Basal and Squamous Cell Carcinomas: Trends in Data and Practice
Bruce D. Cheson, MD, and Richard I. Fisher, MD, on Lymphoma: Treatment Considerations
James L. Mohler, MD, on Managing Prostate Cancer: NCCN Guidelines Updates
Frederick L. Locke, MD, on Innovative CAR-T Cell Therapies: The Patient Experience
Jeffrey A. Meyerhardt, MD, MPH, on Colon Cancer: Results From the ACTS-CC 02 Trial on Adjuvant Chemotherapy
Paul G. Richardson, MD, on Relapsed or Refractory Multiple Myeloma: Adding Isatuximab to Pomalidomide and Low-Dose Dexamethasone

Advertisement

Advertisement



;
Advertisement